Private Equity 3 Days

Last updated: June 15, 2026, 8:33 AM ET

European Footwear and Debt Markets

Birkenstock, the German sandal icon steered by private‑equity owner L Catterton, has announced a €900m bond issuance that will fund a wave of share buybacks after a five‑year hiatus. The move follows a broader trend of European consumer brands tapping debt to shore up cash flow as earnings rebound from pandemic‑era disruptions. The bond will be listed in mid‑June, with proceeds earmarked for buybacks that are expected to lift the company’s share price by roughly 3‑4% once the debt sits on the balance sheet. The timing aligns with the European banking sector’s tightening liquidity stance, which has pushed firms toward high‑yield instruments to secure cheaper capital. The deal also signals confidence from L Catterton in the resilience of discretionary spending amid a recovering eurozone economy. Birkenstock lines up €900m bond to fund buybacks

Healthcare Private‑Equity Hotspot

Private‑equity investors across Europe are sharpening focus on healthcare sub‑sectors that blend technology with reimbursement certainty. Arlington Capital Partners, Bain Capital, EQT, HIG Capital, Mérieux Equity Partners, One Equity Partners, Permira, Vistria Group and Wind Ros are all probing opportunities where digital health solutions can unlock value through data integration and cost‑control. The group notes that AI‑enabled diagnostics and telemedicine platforms are particularly attractive because they can generate recurring revenue streams while meeting evolving payer requirements. This shift mirrors a broader narrative that technology is reshaping the traditional healthcare value chain, prompting investors to prioritize firms that can demonstrate measurable outcomes and defensible market positions. Sector Spotlight: Healthcare investors seek winners amid tech transformation and reimbursement shake‑up

Saa S Re‑imagined in the Age of LLMs

The Software‑as‑a‑Service (Saa S) model is undergoing a recalibration as large language models (LLMs) replace conventional coding paradigms. Founders are now compelled to pivot from purely feature‑driven roadmaps toward outcome‑oriented product suites that deliver tangible business metrics. This transition is driven by a growing expectation from buyers that software must not only integrate seamlessly with existing workflows but also produce defensible, workflow‑owned data assets. As a result, valuation multiples for Saa S firms that can prove high customer retention and deep integration are stabilizing, while those that remain feature‑centric risk being discounted. The trend underscores a broader shift in venture capital toward platforms that can generate measurable ROI rather than just incremental functionality. Rewriting Your Pitch: SaaS Isn’t Dead, But The Playbook For Founders Is Changing

AI Funding Imbalance Between the U.S. and the Rest of the World

Crunchbase data show that U.S. companies have secured nearly 80% of global seed‑through‑growth‑stage AI funding in 2026, a stark contrast to the more balanced distribution seen during earlier AI surges. The concentration reflects a combination of deeper venture ecosystems, more robust corporate venture arms, and a higher density of AI talent in the United States. European and Asian markets, while active, lag in attracting comparable capital, leading to a talent and innovation gap that could widen over the next few years. The disparity also pressures European founders to seek co‑investment from U.S. firms or to pivot toward hybrid models that blend AI with traditional sectors. The AI Startup Funding Boom Is Not A Global Phenomenon

Boots Chain Sale Loses a Key Bidding Partner

Sycamore Partners’ bid to sell the UK pharmacy chain Boots collapsed after Australia’s Sigma Healthcare withdrew from the process. Sigma’s exit was prompted by valuation disagreements and concerns over the strategic fit with its existing health‑care portfolio. The loss of a suitor has forced Sycamore to reassess its exit strategy, potentially delaying the transaction until a higher‑valued buyer emerges. The development highlights the fragility of cross‑border deals in the retail‑health sector, where regulatory scrutiny and brand equity must be balanced against financial returns. Sycamore’s Boots sale loses a suitor as Sigma Healthcare withdraws

Credit Vehicle Targets Strong Pipeline in Europe

Blue Owl’s €355m credit vehicle, managed by Veld Capital, has secured its first tranche of capital to support a robust pipeline of European mid‑cap opportunities. The fund’s strategy focuses on leveraged buyouts and recapitalisations that can generate high yield and upside through operational improvements. By committing follow‑on capital early, Veld Capital aims to capture upside from deal flow that is expected to swell as European debt markets remain accommodative. The move underscores a broader trend of private‑equity‑backed credit vehicles stepping in to fill the gap left by traditional banks, which are tightening lending standards amid regulatory pressure. Blue Owl leads Veld Capital’s €355m credit CV

Strategic Exit from Power‑Grid Protection

Aurelius has divested its protection‑relay business, SEG Electronics, to Spanish conglomerate Arteche Group. The transaction follows Aurelius’s strategy to exit non‑core industrial units and concentrate on higher‑margin sectors such as renewable energy infrastructure. SEG Electronics, which supplies over 300 customers across more than 50 countries, will benefit from Arteche’s global footprint and R&D capabilities, positioning it to capture growth in smart‑grid deployments. The sale reflects a broader private‑equity trend of spinning off mature manufacturing units to free capital for next‑generation technology investments. Aurelius exits protection relay biz SEG Electronics to Arteche Group

Family Office Restructuring at Partners Group

Urs Wietlisbach, co‑founder of Swiss private‑equity powerhouse Partners Group, is carving out a separate unit within the family office to manage his personal wealth. The split is part of a succession plan that aims to preserve the firm’s legacy while allowing Wietlisbach to pursue independent investment opportunities. The move follows a pattern among high‑net‑worth founders who seek to balance control with liquidity, ensuring that future generations can benefit from the firm’s assets without compromising strategic direction. The restructuring also signals a shift in how elite private‑equity families manage intergenerational wealth in an era of increased regulatory scrutiny. Partners Group co‑founder Wietlisbach splits family office in succession move

Retail Investor Redemptions in Private Credit Narrow

BlackRock has capped redemptions from its flagship $13bn private‑credit fund for a second consecutive quarter, a response to persistent outflows from retail investors seeking liquidity. The cap limits withdrawals to 1% of the fund’s net asset value, protecting the remaining capital base from forced asset sales that could erode returns. The move reflects a broader trend of retail investors retreating from illiquid assets amid market volatility, while institutional players continue to seek stable, long‑term credit exposures. BlackRock’s action illustrates the delicate balance firms must maintain between investor demand for liquidity and the need to preserve portfolio integrity. BlackRock caps redemptions on $13bn private credit fund for second quarter running

Strategic Acquisitions in Healthcare and Advisory Services

KKA and Winterberg-backed Healthcare Holding Schweiz has added Compet Medical, a provider of harm‑reduction products, to its portfolio, expanding its reach into preventive health solutions for public institutions. The acquisition positions the holding to capture growing demand for community‑based health services across Europe, where aging populations are driving spending on preventive care. In a parallel move, KKR has invested in CPA firm Crowe’s advisory business, becoming its first institutional partner. The partnership will enable Crowe to scale its consulting services across North America and Europe, leveraging KKR’s capital and network to accelerate growth in audit and advisory. These deals highlight a sectoral shift toward integrated health and professional services, where private‑equity backing fuels expansion and operational excellence. KKA, Winterberg-backed Healthcare Holding Schweiz acquires Compet Medical

Public Pension Fund Elevates Private‑Markets Leadership

CalPERS, the United States’ largest public pension fund, has promoted Anton Orlich to deputy chief investment officer for private markets, following a period of record returns for its PE investments. The promotion comes as CalPERS seeks to deepen its expertise in alternative assets amid rising competition for top‑tier deals. Orlich’s new role will focus on sourcing high‑quality opportunities, managing risk, and enhancing governance across the fund’s private‑equity portfolio. The move signals CalPERS’ commitment to maintaining its leadership position in the alternative‑asset space while navigating a tightening capital‑market environment. CalPERS promotes Anton Orlich to lead private markets after top‑ranked PE returns